Tandem Diabetes Care (TNDM) Return on Capital Employed (2014 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Return on Capital Employed came in at 10.89% in Q1 2026, up 1626.0% YoY from 0.63% in Q1 2025, and up 63.05% on a QoQ basis from 29.48% in Q4 2025.
Tandem Diabetes Care (TNDM) Return on Capital Employed (2014 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Return on Capital Employed data on file, last reported at 10.89% in Q1 2026.
- Quarterly Return on Capital Employed rose 1626.0% year-over-year to 10.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.89% (up 1626.0% YoY) and the FY2025 annual result came in at 27.47%, down 1357.0% from the prior year.
- Return on Capital Employed advanced to 10.89% in Q1 2026, from 29.48% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1.27% in Q1 2022 to a low of 31.5% in Q3 2025.
- A 5-year average of 19.64% and a median of 19.9% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 2909 bps — and 2024, when it surged 1720 bps.
- Tracing TNDM's Return on Capital Employed over 5 years: stood at 10.49% in 2022, then plunged by 196 bps to 31.05% in 2023, then soared by 55 bps to 13.85% in 2024, then tumbled by 113 bps to 29.48% in 2025, then surged by 63 bps to 10.89% in 2026.
- The last three Return on Capital Employed figures came in at 10.89% (Q1 2026), 29.48% (Q4 2025), and 31.5% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -5.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.08% |
| Mar 31, 2026 | -10.89% |
| Dec 31, 2025 | -29.48% |
| Sep 30, 2025 | -31.50% |
| Jun 30, 2025 | -30.80% |
| Mar 31, 2025 | -27.15% |
| Dec 31, 2024 | -13.85% |
| Sep 30, 2024 | -19.41% |
| Jun 30, 2024 | -19.90% |
| Mar 31, 2024 | -19.51% |
| Dec 31, 2023 | -31.05% |
| Sep 30, 2023 | -28.56% |
| Jun 30, 2023 | -29.89% |
| Mar 31, 2023 | -24.67% |
| Dec 31, 2022 | -10.49% |
| Sep 30, 2022 | -7.18% |
| Jun 30, 2022 | -0.80% |
| Mar 31, 2022 | 1.27% |
| Dec 31, 2021 | 3.04% |
| Sep 30, 2021 | 4.06% |